Tachyarrhythmia clinical trials at UCSD

1 in progress, 0 open to eligible people

Lead Evaluation for Defibrillation and Reliability Post Approval Study
Sorry, accepting new patients by invitation only
Medtronic is sponsoring the LEADR PAS to provide continuing evaluation and periodic reporting of safety and effectiveness of the OmniaSecure™ defibrillation lead following commercial release. The LEADR PAS is conducted within Medtronic's Product Surveillance Registry Platform (NCT01524276).
La Jolla, California and other locations

Last updated: October 30, 2026

Lead Evaluation for Defibrillation and Reliability Post Approval Study